Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

INTERLEUKIN 15

IL-15 in autoimmunity and cancer: O-tu-b or not O-tu-b?

Nature Immunology volume 20, pages 780–782 (2019)Cite this article

The cytokine IL-15 controls the homeostasis and activation of CD8+ T cells and natural killer cells. A new study reveals the deubiquitinase Otub1 to be a negative regulator of IL-15 signaling, with important consequences for autoimmunity and anti-cancer immunity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Otub1 negatively regulates IL-15 signaling in CD8+ T cells and NK cells.

References

  1. Kurioka, A., Klenerman, P. & Willberg, C.B. Immunology https://doi.org/10.1111/imm.12925 (2018).

    Article  CAS  Google Scholar 

  2. Lin, J. X. & Leonard, W. J. Cold Spring Harb. Perspect. Biol. 10, a028449 (2018).

    Article  Google Scholar 

  3. Zhou, X. et al. Nat. Immunol. https://doi.org/10.1038/s41590-019-0405-2 (2019).

    Article  CAS  Google Scholar 

  4. Castillo, E. F. & Schluns, K. S. Cytokine 59, 479–490 (2012).

    Article  CAS  Google Scholar 

  5. Deshpande, P. et al. J. Immunol. 190, 1416–1423 (2013).

    Article  CAS  Google Scholar 

  6. Hao, M. et al. Biochem. Pharmacol. 147, 128–140 (2018).

    Article  CAS  Google Scholar 

  7. Yuan, L. et al. Am. J. Cancer Res. 7, 159–172 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Herhaus, L. et al. Sci. Signal. 8, ra35 (2015).

    Article  Google Scholar 

  9. Li, Y. et al. J. Biol. Chem. 289, 5097–5108 (2014).

    Article  CAS  Google Scholar 

  10. Scholz, C. C. et al. PLoS Biol. 14, e1002347 (2016).

    Article  Google Scholar 

  11. Saldana, M., VanderVorst, K., Berg, A. L., Lee, H. & Carraway, K. L. Endocr. Relat. Cancer 26, R1–R14 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Maynooth University Human Health Research Institute, National University of Ireland Maynooth, Maynooth, Ireland

    Paul N. Moynagh

  2. Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry & Biomedical Science, Queen’s University Belfast, Belfast, UK

    Paul N. Moynagh

Authors
  1. Paul N. Moynagh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul N. Moynagh.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moynagh, P.N. IL-15 in autoimmunity and cancer: O-tu-b or not O-tu-b?. Nat Immunol 20, 780–782 (2019). https://doi.org/10.1038/s41590-019-0424-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-019-0424-z

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing